Francisco Bravo

University of Bern — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index574citations13works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(10), Microscopic Colitis(4), Immunodeficiency and Autoimmune Disorders(3), Gut microbiota and health(1), Antifungal resistance and susceptibility(1)

Publications13 total

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
European Journal of Gastroenterology & Hepatology·2022· 8 citedOpen Access
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
Nature Communications·2022Open Access
P648 Prevalence and Impact of Alcohol Consumption and Cannabis Use on Inflammatory Bowel Diseases
Journal of Crohn s and Colitis·2022Open Access
Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up
Clinical and Translational Gastroenterology·2021· 4 citedOpen Access
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
Therapeutic Advances in Gastroenterology·2021· 16 citedOpen Access
Progressive malnutrition despite percutaneous endoscopic gastrostomy
Frontline Gastroenterology·2020Open Access
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
Nature Communications·2020· 64 citedOpen Access
P650 Outcomes of endoscopic balloon dilation for luminal strictures in Crohn’s disease
Journal of Crohn s and Colitis·2020Open Access
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn’s disease
Nature Medicine·2019· 17 citedOpen Access
P587 Quality of care indicators in inflammatory bowel disease: local pilot study
Journal of Crohn s and Colitis·2019Open Access
Microbial network disturbances in relapsing refractory Crohn’s disease
Nature Medicine·2019· 430 citedOpen Access
Mo1839 - Long-Term Prediction of Infliximab Response using CD-62L Shedding Assay: Longitudinal Data from 5-Year Study in Inflammatory Bowel Disease
Gastroenterology·2018
Lobomycosis Successfully Treated with Posaconazole
American Journal of Tropical Medicine and Hygiene·2013· 35 citedOpen Access

Frequent Co-authors

Pascal Juillerat(11), Andrew J. Macpherson(8), Yannick Franc(7), Valérie Pittet(7), Reiner Wiest(6), Gerhard Rogler(5), Bahtiyar Yılmaz(4), Ove Øyås(4), Charlotte Ramon(4), Nicolas Fournier(4), Pierre Michetti(4), Markus B. Geuking(4), Michel H. Maillard(4), Jörg Stelling(4), Luc Biedermann(4), Ioannis Kapoglou(4), Christian Braegger(3), Lukas Brügger(3), Ove Carstens(3), Ulrike Graf Bigler(3)